Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hôpital de Verdun
We will compare various clinically relevant outcomes in patients treated for type II (hypercapnic) acute respiratory failure (ARF) with either High-Flow Nasal Cannula (HFNC) or Non-Invasive Ventilation (NIV) in a general adult hospital.
All patients treated with HFNC were treated with an Optiflow device (Fisher\&Paykel). Various Bilevel positive airway pressure (BiPAP) devices were used during the study period.
All ventilatory parameters were set according to the treating physicians' preferences.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All patients treated with respiratory failure not responding to conventional supplemental oxygen therapy
Blood venous gas showing partial pressure of carbon dioxide\>50 mmHg before beginning therapy with either NIV or HFNC
You may not be if
Lack of records of the primary outcome
End-of-life care
Lack of gas before the beginning of NIV or HFNC
Clareo Health | Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure
